Skip to main content
Sign in Create a free account
Varsity Tutors
Sign in

Preparation And Routes - NAPLEX

  1. A 66-year-old man (weight 85 kg) is admitted with severe pain from metastatic prostate cancer; treatment goal is continuous analgesia with minimal peaks and troughs. Current medications: morphine immediate-release 15 mg orally every 4 hours as needed (insufficient), ondansetron 4 mg orally every 8 hours as needed. He has difficulty swallowing pills due to mucositis. Labs: serum creatinine 1.0 mg/dL. Allergies: none. Which administration route is most appropriate for this patient?
    Answer: Switch to transdermal fentanyl patch after assessing opioid tolerance and provide short-acting opioid for breakthrough pain This question tests alternative routes for opioid analgesia in patients with swallowing difficulties. Key patient-specific factors include metastatic cancer pain, mucositis, and insufficient oral morphine. Switching to transdermal fentanyl after assessing tolerance with breakthrough opioid is appropriate for continuous relief without oral intake. Crushing extended-release is unsafe; nebulized not indicated; discontinuation inadequate. A transferable clinical pearl is to use transdermal for stable chronic pain in dysphagic patients. For route selection, evaluate pain patterns and tolerance.
  2. A 59-year-old man (weight 95 kg) is being treated for acute deep vein thrombosis; treatment goal is therapeutic anticoagulation without dosing errors. Current order: heparin infusion prepared as 25,000 units in 250 mL 0.45% sodium chloride (100 units/mL) with titration based on activated partial thromboplastin time (aPTT); baseline aPTT is 30 seconds. Allergies: none. What is the most critical preparation step for this medication?
    Answer: Use an independent double-check of the heparin concentration, patient weight-based protocol, and pump settings prior to administration This question tests critical preparation steps for high-alert anticoagulants like heparin infusions to prevent dosing errors. Key patient-specific factors include the patient's weight, deep vein thrombosis diagnosis, baseline aPTT, and titration protocol. Using an independent double-check of the heparin concentration, patient weight-based protocol, and pump settings prior to administration is most critical to ensure accuracy and safety. Adding to maintenance fluids risks incompatibility; concentrated preparations increase error risk; prolonged room temperature storage reduces stability. Critical steps include verifying calculations and using smart pumps, with common pitfalls being weight errors or unverified programming. A transferable framework is to implement layered safeguards like double-checks for all high-alert infusions to mitigate harm.
  3. A 6-year-old boy (weight 20 kg) with an acute asthma exacerbation is prescribed albuterol metered-dose inhaler (90 mcg per actuation): 2 puffs every 4 hours as needed; treatment goal is rapid bronchodilation with correct technique. He has difficulty coordinating actuation and inhalation; caregiver prefers an approach that is easy to perform at home. Allergies: none. What counseling point is essential for this route of administration?
    Answer: Use a valved holding chamber (spacer) with the metered-dose inhaler and have the child inhale slowly and deeply after actuation This question evaluates proper inhaler technique counseling for a pediatric patient with coordination difficulties. The child's inability to coordinate actuation with inhalation is a common barrier to effective bronchodilator delivery in young patients. Using a valved holding chamber (spacer) with slow, deep inhalation after actuation (A) is essential because it eliminates the need for coordination, increases lung deposition from 10% to 20-30%, and reduces oropharyngeal deposition. Exhaling into the mouthpiece (B) is incorrect technique that could damage the device and reduce dose delivery. Mouth rinsing after albuterol (C) is unnecessary because albuterol doesn't cause oral candidiasis - this applies to inhaled corticosteroids. Swallowing medication after actuation (D) defeats the purpose of inhalation therapy and increases systemic side effects. The clinical pearl is that spacers are particularly valuable for children under 8 years old, elderly patients, and anyone with coordination difficulties, making inhaled therapy accessible and effective.
  4. A 67-year-old man (weight 80 kg) with chronic obstructive pulmonary disease (COPD) is prescribed tiotropium HandiHaler for the treatment goal of reducing exacerbations. Current medications: tiotropium 18 mcg capsule for inhalation once daily; albuterol MDI as needed. Spirometry shows FEV1 52% predicted. Allergies: none. What counseling point is essential for this route of administration?
    Answer: Pierce the capsule in the HandiHaler and inhale the powder; do not swallow the capsule This question tests counseling for dry powder inhalers like tiotropium HandiHaler, emphasizing proper technique. Key patient-specific factors include COPD diagnosis, reduced FEV1, and daily maintenance use. Piercing the capsule in the HandiHaler and inhaling the powder without swallowing is essential for correct delivery to the lungs. Swallowing provides no benefit; using only as needed defeats maintenance purpose; rinsing capsules alters integrity. A transferable clinical pearl is that inhalation capsules must never be ingested to avoid systemic inefficacy. For device counseling, demonstrate technique and confirm understanding to optimize therapy.
  5. A 58-year-old woman (weight 69 kg) is receiving total parenteral nutrition (TPN) and requires potassium replacement; treatment goal is safe correction of hypokalemia. Current order: potassium chloride 20 mEq IV; potassium is 2.9 mEq/L, magnesium is 1.8 mg/dL, serum creatinine is 0.7 mg/dL. Allergies: none. What is the most critical preparation step for this medication?
    Answer: Dilute potassium chloride in an appropriate IV fluid and infuse using a controlled rate (pump) per institutional limits This question tests safe preparation of potassium chloride infusions to prevent cardiac complications. Key patient-specific factors include TPN use, hypokalemia, normal magnesium, and renal function. Diluting in IV fluid and infusing at controlled rates per limits is critical for safety. IV push is dangerous; bedside mixing risks errors; prolonged storage unstable. Critical steps include pump use and monitoring, pitfalls like rapid infusion. A transferable framework is to never push concentrated potassium and verify admixtures.
  6. A 52-year-old man (weight 82 kg) with methicillin-resistant Staphylococcus aureus (MRSA) bacteremia is receiving vancomycin 1,250 mg intravenously every 12 hours; goal is trough-guided therapy with a target trough of 15–20 mg/L. Current labs: serum creatinine 0.9 mg/dL, vancomycin trough 17 mg/L. He is clinically improving and asks to switch to oral vancomycin to go home. Allergies: none. Which dosage form substitution is most appropriate given this patient's condition?
    Answer: Continue vancomycin intravenously at the current regimen (no oral substitution for bacteremia) This question evaluates understanding of vancomycin's route-specific indications and the fundamental principle that oral vancomycin is not absorbed systemically. The patient has MRSA bacteremia requiring systemic therapy, with therapeutic vancomycin levels achieved intravenously. Continuing vancomycin intravenously (C) is the only appropriate option because oral vancomycin has negligible systemic bioavailability (<5%) and is only indicated for gastrointestinal infections like C. difficile colitis. Switching to oral vancomycin at any dose (A, D) would result in subtherapeutic systemic levels and treatment failure for bacteremia. Linezolid 600 mg orally (B), while having excellent oral bioavailability for MRSA, represents an unnecessary change when the patient is responding well to vancomycin with therapeutic levels. The clinical pearl is that vancomycin's oral formulation is exclusively for local GI effects, never for systemic infections, regardless of dose or patient preference for oral therapy.
  7. A 52-year-old woman (weight 83 kg) with breast cancer is scheduled for outpatient chemotherapy; treatment goal is safe sterile preparation of doxorubicin. Current regimen includes doxorubicin 60 mg/m2m^2 IV on day 1; body surface area is 1.8 m2m^2 (dose 108 mg). Labs: absolute neutrophil count 2.1 x103x10^3/mcL, total bilirubin 0.8 mg/dL. Allergies: none. What is the most critical preparation step for this medication?
    Answer: Prepare doxorubicin in a certified biological safety cabinet or compounding aseptic containment isolator using appropriate hazardous drug personal protective equipment This question tests the safe preparation of hazardous drugs like doxorubicin, emphasizing sterile compounding in controlled environments with proper protective measures. Key patient-specific factors include the patient's breast cancer diagnosis, calculated dose based on body surface area, normal neutrophil count, and normal bilirubin indicating no hepatic impairment. Preparing doxorubicin in a certified biological safety cabinet or compounding aseptic containment isolator using appropriate hazardous drug personal protective equipment is the most critical step to ensure sterility, prevent contamination, and protect the preparer from exposure. Using non-sterile gloves on an open countertop risks exposure and contamination; filtering does not remove hazardous properties; autoclaving is inappropriate as it would degrade the drug. Critical steps include using closed-system transfer devices, double-gloving, and proper waste disposal, with common pitfalls being inadequate PPE or environmental controls. A transferable framework is to follow USP <800> guidelines for all hazardous drugs to minimize risks to healthcare workers and patients.
  8. A 33-year-old man (weight 70 kg) with moderate persistent asthma has a treatment goal of improving symptom control and preventing exacerbations. Current medications: budesonide/formoterol 160/4.5 mcg inhaler, 2 inhalations twice daily; albuterol metered-dose inhaler (MDI) 2 inhalations every 4 to 6 hours as needed. Peak flow today is 420 L/min (personal best 520 L/min). Allergies: none. What counseling point is essential for this route of administration?
    Answer: Rinse the mouth and spit after using the budesonide/formoterol inhaler to reduce risk of oral candidiasis This question tests essential counseling for inhaled corticosteroids in asthma management, focusing on techniques to minimize adverse effects. Key patient-specific factors include the patient's moderate persistent asthma, current regimen with budesonide/formoterol and albuterol, and reduced peak flow indicating suboptimal control. Rinsing the mouth and spitting after using the budesonide/formoterol inhaler is essential to reduce the risk of oral candidiasis, a common side effect of inhaled corticosteroids. Incorrect techniques like exhaling into the mouthpiece or storing in the freezer can compromise dose delivery and drug stability; using only when symptomatic defeats the controller purpose. A transferable clinical pearl is that proper inhaler technique and post-use rinsing are key to maximizing benefits and minimizing local adverse effects in asthma therapy. For inhalation routes, always provide device-specific education and monitor for adherence to improve outcomes.
  9. A 45-year-old woman (weight 62 kg) is hospitalized with pyelonephritis; treatment goal is to step down to oral antibiotics after clinical improvement. Current therapy: ciprofloxacin 400 mg IV every 12 hours; she is afebrile, tolerating oral intake, and flank pain is improving. Labs: serum creatinine 0.8 mg/dL; urine culture grows Escherichia coli susceptible to ciprofloxacin. Allergies: none. Which dosage form substitution is most appropriate given this patient's condition?
    Answer: Switch to ciprofloxacin 500 mg orally every 12 hours This question tests IV-to-oral antibiotic step-down for pyelonephritis, considering bioavailability and dosing equivalence. Key patient-specific factors include clinical improvement, normal renal function, susceptibility to ciprofloxacin, and tolerance of oral intake. Switching to ciprofloxacin 500 mg orally every 12 hours is most appropriate due to its high oral bioavailability and equivalent dosing to IV for uncomplicated cases. Lower dosing is inadequate; ophthalmic drops are not systemic; continuing IV unnecessarily prolongs hospitalization. A transferable clinical pearl is that ciprofloxacin has near 100% oral bioavailability, allowing 1:1 IV-to-oral conversion. For step-down decisions, evaluate stability and use agents with excellent absorption to facilitate discharge.
  10. A 29-year-old woman (weight 54 kg) with migraine has severe nausea and vomiting; treatment goal is rapid symptom relief without oral administration. Current medications: sumatriptan 100 mg tablets as needed (unable to keep down), ondansetron 4 mg orally disintegrating tablets as needed. Pregnancy test negative. Allergies: sulfonamide antibiotics (rash). Which administration route is most appropriate for this patient?
    Answer: Switch to sumatriptan subcutaneous injection This question tests non-oral administration routes for migraine relief in patients with severe nausea and vomiting. Key patient-specific factors include inability to tolerate oral sumatriptan, negative pregnancy test, and sulfonamide allergy (not contraindicating sumatriptan). Switching to sumatriptan subcutaneous injection is most appropriate for rapid onset and bypassing gastrointestinal issues. Advising oral with meals may worsen vomiting; extended-release cannot be opened; topical cream is not available. A transferable clinical pearl is that subcutaneous triptans provide the fastest relief for migraines with emesis. For route selection, consider barriers like nausea and choose formulations with quick absorption.
  11. A 64-year-old woman (weight 70 kg) with community-acquired pneumonia is receiving azithromycin 500 mg intravenously every 24 hours plus ceftriaxone 1 g intravenously every 24 hours. After 48 hours, she is afebrile, hemodynamically stable, tolerating a regular diet, and has a functioning gastrointestinal tract; white blood cell count decreased from 14.2 to 9.8 x103x10^3/µL. Allergies: none. Which dosage form substitution is most appropriate given this patient's condition?
    Answer: Convert azithromycin to 500 mg by mouth once daily This question tests the appropriate conversion from intravenous to oral antibiotics in a clinically stable patient with community-acquired pneumonia. The key factors are clinical improvement (afebrile, hemodynamically stable), functioning GI tract, and ability to tolerate oral intake, which support IV-to-PO conversion. Converting azithromycin to 500 mg by mouth once daily (A) is correct because azithromycin has excellent oral bioavailability (37-40%) and the same daily dose is used for both IV and oral routes in pneumonia treatment. Option B (250 mg daily without loading) would provide subtherapeutic dosing for pneumonia. Intramuscular administration (C) is unnecessary when oral route is available and would cause patient discomfort. Continuing IV therapy (D) is inappropriate because azithromycin has reliable oral absorption in patients with functioning GI tracts. The principle of early IV-to-PO conversion reduces costs, IV complications, and facilitates earlier discharge while maintaining therapeutic efficacy in appropriate candidates.
  12. A 59-year-old man (weight 75 kg) is receiving total parenteral nutrition through a central line and develops a catheter-associated bloodstream infection. The prescriber orders vancomycin 1 g in 250 mL 0.9% sodium chloride intravenously every 12 hours; treatment goal is safe infusion with minimized phlebitis and infusion reactions. Allergies: none. What is the most critical preparation step for this medication before administration?
    Answer: Label the infusion with drug name, total dose, total volume, concentration, beyond-use time, and infusion duration This question addresses critical preparation steps for intravenous medications, focusing on proper labeling to prevent medication errors. The patient's central line infection requires vancomycin therapy with appropriate safety measures. Comprehensive labeling with drug name, dose, volume, concentration, beyond-use time, and infusion duration (A) is the most critical step because it ensures all healthcare providers can verify the correct medication, dose, and administration parameters, preventing errors throughout the medication use process. Adding vancomycin to TPN (B) is contraindicated due to incompatibility and infection control concerns. Filtering through 0.22-micron filters only if precipitate is visible (C) is reactive rather than proactive; vancomycin doesn't require routine filtration. Diluting in sterile water only (D) is incorrect; vancomycin is compatible with normal saline, which is the standard diluent. The principle is that complete, accurate labeling is the foundation of IV medication safety, enabling verification at every step from preparation through administration.
  13. A 5-year-old girl (weight 18 kg) with fever and pain has a treatment goal of symptom relief at home. Current prescription: acetaminophen 160 mg/5 mL oral suspension, 7.5 mL by mouth every 6 hours as needed; she gags with syringes and the caregiver asks to mix it into a full bottle of juice for the day. Labs: none relevant. Allergies: none. Which administration route is most appropriate for this patient?
    Answer: Measure each dose with an oral dosing syringe or dosing cup and administer immediately; do not mix the full day's dose into a large volume of beverage This question tests safe administration of oral suspensions in children, avoiding mixing errors. Key patient-specific factors include fever, gagging with syringes, and caregiver request to mix in juice. Measuring with dosing syringe and administering immediately without full-day mixing is appropriate to ensure accurate dosing and stability. Bulk mixing risks uneven distribution; inhalation or sublingual not indicated. A transferable clinical pearl is to dose liquids precisely and avoid dilution unless specified. For pediatrics, educate on tools to prevent errors.
  14. A 50-year-old man (weight 88 kg) is receiving a continuous infusion of norepinephrine for septic shock; treatment goal is maintain mean arterial pressure (MAP) ≥ 65 mmHg while preventing dosing errors. Current order: norepinephrine 4 mg in 250 mL 5% dextrose in water (16 mcg/mL) via central line; MAP is 58 mmHg. Allergies: none. What is the most critical preparation step for this medication?
    Answer: Use standardized concentrations, label the infusion clearly in mcg/mL, and require an independent double-check before starting the infusion This question tests preparation of vasopressor infusions like norepinephrine for error prevention in shock. Key patient-specific factors include septic shock, subtherapeutic MAP, and central line use. Using standardized concentrations, clear labeling, and double-checks is critical for safety. Nonstandard increases errors; intramuscular not indicated; light exposure degrades. Critical steps include verification and pump use, pitfalls like mislabeling. A transferable framework is standardization and checks for critical infusions.
  15. A 78-year-old woman (weight 60 kg) is admitted after an acute ischemic stroke with new dysphagia and is currently nil per os (nothing by mouth). Treatment goal is secondary stroke prevention. Home medications include aspirin 81 mg by mouth daily, atorvastatin 40 mg by mouth nightly, and lisinopril 10 mg by mouth daily; she has no feeding tube in place. Allergies: anaphylaxis to penicillin. Which administration route is most appropriate to continue antiplatelet therapy at this time?
    Answer: Aspirin 300 mg rectal suppository once daily This question tests the appropriate route of administration for antiplatelet therapy in a patient with dysphagia who cannot take medications orally. The key patient-specific factors are the acute stroke with new dysphagia, nil per os status, and absence of a feeding tube, which eliminate all oral routes. Aspirin 300 mg rectal suppository once daily (B) is the best choice because it provides reliable systemic absorption through the rectal mucosa when oral administration is contraindicated. Aspirin 81 mg enteric-coated tablet by mouth (A) and aspirin 81 mg crushed in water by mouth (D) are both contraindicated due to the patient's NPO status and aspiration risk. Clopidogrel 75 mg by mouth (C) is also contraindicated for the same reason, and switching antiplatelet agents is unnecessary when an alternative route exists. When patients cannot take medications orally and lack enteral access, rectal administration often provides a viable alternative for medications available in suppository form, maintaining therapeutic continuity without invasive procedures.
  16. A 41-year-old woman (weight 62 kg) with breast cancer is scheduled for outpatient chemotherapy with doxorubicin 60 mg IV today; treatment goal is safe administration and prevention of occupational exposure. Baseline labs: absolute neutrophil count 2.1 x103x10^3/µL, platelets 210 x103x10^3/µL, total bilirubin 0.8 mg/dL; echocardiogram shows left ventricular ejection fraction 60%. Allergies: none. What is the most critical preparation step for this medication?
    Answer: Prepare and spike the doxorubicin dose using a closed-system transfer device in a certified biological safety cabinet This question evaluates safe handling procedures for hazardous chemotherapy agents. The patient is receiving doxorubicin, an anthracycline chemotherapy requiring specialized preparation to protect healthcare workers from occupational exposure. Using a closed-system transfer device in a certified biological safety cabinet (A) is critical because it prevents aerosolization and environmental contamination while maintaining sterility during preparation. Compounding on an open countertop (B) exposes personnel to hazardous drug vapors and violates USP <800> standards. Using non-sterile gloves (C) is inadequate; chemotherapy preparation requires chemotherapy-rated gloves, often double-gloving, regardless of administration route. Oral administration in water (D) is incorrect as doxorubicin is only given intravenously and requires careful administration to prevent extravasation. The fundamental principle is that all hazardous drugs require engineering controls (safety cabinet), administrative controls (policies/procedures), and personal protective equipment to minimize occupational exposure during all handling steps.
  17. A 56-year-old woman (weight 74 kg) with type 1 diabetes uses insulin glargine U-100 for the treatment goal of basal glycemic control. Current regimen: insulin glargine 24 units subcutaneously nightly and insulin lispro with meals. Most recent fasting glucose is 140 mg/dL. Allergies: none. She asks if she can prefill syringes for the week and keep them on the counter. How should this medication be stored to ensure stability?
    Answer: Store unopened insulin in the refrigerator; once in use, keep per product labeling (often room temperature) and avoid freezing or heat; do not store prefilled syringes unless specifically instructed This question tests storage guidelines for insulin products to preserve potency. Key patient-specific factors include type 1 diabetes, basal insulin regimen, and request for prefilled syringes. Storing unopened insulin in the refrigerator and in-use per labeling, avoiding prefilled syringes unless specified, ensures stability. Prefilling for 30 days risks contamination; freezing or sunlight damages insulin. A transferable clinical pearl is that insulin is heat-sensitive and should not be frozen or exposed to extremes. For storage, follow product-specific guidelines and discourage bulk prefilling to prevent errors.
  18. A 60-year-old man (weight 77 kg) with heart failure with reduced ejection fraction is admitted for volume overload; treatment goal is effective diuresis with transition to oral therapy prior to discharge. Current medications: furosemide 40 mg IV twice daily; home regimen was furosemide 40 mg orally daily. He is improving and no longer has nausea. Labs: sodium 138 mEq/L, potassium 3.9 mEq/L, serum creatinine 1.1 mg/dL. Allergies: none. Which dosage form substitution is most appropriate given this patient's condition?
    Answer: Switch to furosemide 40 mg orally twice daily This question tests IV-to-oral conversion for loop diuretics in heart failure, accounting for bioavailability differences. Key patient-specific factors include volume overload improvement, no nausea, normal electrolytes, and prior home dose. Switching to furosemide 40 mg orally twice daily is appropriate to match the increased IV dosing needs due to ~50% oral bioavailability. Once-daily oral under-doses; ophthalmic not oral; continuing IV delays discharge. A transferable clinical pearl is to double the oral dose when converting from IV furosemide to account for absorption. For conversions, consider disease state and monitor response.
  19. A 64-year-old woman (weight 58 kg) with type 2 diabetes is NPO after abdominal surgery; treatment goal is safe glycemic control in the ICU. Current orders: insulin regular infusion (high-alert) prepared as 100 units in 100 mL 0.9% sodium chloride (1 unit/mL) IV with titration per protocol; point-of-care glucose is 312 mg/dL and potassium is 4.2 mEq/L. Allergies: none. The nurse asks what step is most important to prevent an administration error with this medication. What is the most critical preparation step for this medication?
    Answer: Use a smart pump drug library and obtain an independent double-check of the insulin concentration and pump settings This question tests the safe preparation and administration of high-alert medications like insulin infusions, emphasizing error prevention strategies in critical care settings. Key patient-specific factors include the patient's NPO status post-surgery, elevated blood glucose, normal potassium, and the use of a concentrated insulin infusion with titration protocol. Using a smart pump drug library and obtaining an independent double-check of the insulin concentration and pump settings is the most critical step to prevent administration errors, as it ensures accuracy in dosing and programming for this high-risk medication. Priming with 0.9% sodium chloride is unnecessary since insulin adsorbs to tubing but is mitigated by standard flushing; preparing with 5% dextrose in water is not standard and may complicate hypoglycemia management; adding insulin at the bedside increases error risk without sterile conditions. Critical steps include verifying the concentration (1 unit/mL), patient weight, and protocol adherence, with common pitfalls being calculation errors or pump misprogramming. A transferable framework is to always employ double-checks and technology safeguards for high-alert infusions to enhance patient safety.
  20. A 24-year-old woman (weight 63 kg) with anaphylaxis to peanuts is prescribed an epinephrine auto-injector for the treatment goal of rapid emergency treatment. Current medications: none. Allergies: peanuts (anaphylaxis). She asks where to inject and how to hold the device. What counseling point is essential for this route of administration?
    Answer: Inject into the mid-outer thigh through clothing if needed and hold in place per device instructions This question tests counseling for epinephrine auto-injectors in anaphylaxis management. Key patient-specific factors include peanut anaphylaxis and need for emergency self-administration. Injecting into the mid-outer thigh through clothing and holding per instructions is essential for rapid intramuscular delivery. Deltoid or buttock sites are suboptimal; subcutaneous abdomen is incorrect. A transferable clinical pearl is that thigh injection ensures best absorption in emergencies. For counseling, emphasize technique and emergency follow-up.

Start this quiz